Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Landos Biopharma Inc (LABP)

Landos Biopharma Inc (LABP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Landos Biopharma Reports Second Quarter 2022 Results and Provides Business Update

Positive Top-Line Results From NX-13 Phase 1b Trial in Ulcerative Colitis Demonstrate a Favorable Safety and Tolerability Profile Across Range of...

LABP : 0.2300 (-6.50%)
The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma

Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma are part of Zacks top Analyst Blog

ANGN : 0.8401 (-8.68%)
APLT : 0.9005 (-3.44%)
LABP : 0.2300 (-6.50%)
BOLT : 1.4000 (-3.45%)
IKNA : 2.23 (-5.51%)
5 Biotech Stocks Set to Outpace Q1 Earnings Estimates

Let us take a look at some drug/biotech stocks, ANGN, APLT, BOLT, IKNA and LABP, which are poised to beat on first-quarter earnings.

ANGN : 0.8401 (-8.68%)
APLT : 0.9005 (-3.44%)
LABP : 0.2300 (-6.50%)
BOLT : 1.4000 (-3.45%)
IKNA : 2.23 (-5.51%)
Why Encompass Health (EHC) is Down 2.4% Since Q1 Earnings Beat

Encompass Health Corporation (EHC) looks to unveil eight additional de novo locations this year and increase its bed count.

ANGN : 0.8401 (-8.68%)
ASND : 119.42 (-4.76%)
EHC : 57.62 (-0.64%)
LABP : 0.2300 (-6.50%)
Perrigo (PRGO) to Report Q1 Earnings: What's in the Cards?

Perrigo's (PRGO) new products as well as products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

ANGN : 0.8401 (-8.68%)
PRGO : 31.81 (-0.41%)
APLT : 0.9005 (-3.44%)
LABP : 0.2300 (-6.50%)
Landos Biopharma Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update

Continued Progress Towards Optimizing Clinical Development Plans On Track to Initiate Phase 2b Study of Omilancor in Ulcerative Colitis Later this Year ...

LABP : 0.2300 (-6.50%)
Landos Biopharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Enhancing Focus on High-Impact Clinical-Stage Programs to Ensure Optimal Path to Commercialization Refining Ulcerative Colitis Clinical...

LABP : 0.2300 (-6.50%)
Should You Buy Landos Biopharma (LABP) Ahead of Earnings?

Landos Biopharma (LABP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

LABP : 0.2300 (-6.50%)
Landos Biopharma Announces Leadership Transition

Josep Bassaganya-Riera Steps Down as Chairman, President and CEO Tim M. Mayleben Appointed Interim President and CEO Chris Garabedian Appointed...

LABP : 0.2300 (-6.50%)
Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Rheumatoid Arthritis

Phase 1 trial is underway with topline results expected in the first half of 2022 Represents Landos’ seventh IND cleared overall and the second IND...

LABP : 0.2300 (-6.50%)

Barchart Exclusives

EPA Proposals Would Bring Major Changes to the U.S. Biofuel Efforts
Last Week’s Moves Corn 640-0 (-4.92%) | Soybeans 1438-6 (-1.41%) | SRW Wheat 737-2 (-5.06%) KC Wheat 846-6 (-5.28%) | Live Cattle 156.150 (+0.97%) | Lean Hogs 90.875 (+7.11%) _________________________________________________________________________________________ Welcome to your weekly agriculture report, where we cover everything you’ll need to know for the week ahead. This week,... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar